Bayer, a global life sciences company, and Henry Ford Health announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communit…
Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital of PolyPeptide Group AG, a leading global contract development and manufacturing organization (CDMO) specializing in peptide-based active pharmaceutical ingredients (APIs). With this transactio…
Servier, an independent international pharmaceutical group governed by a foundation, announced that it has completed the acquisition of the muscular dystrophy business of Edgewise Therapeutics Inc, for up to $2.65 billion, including upfront payment of $1.55 billion as well as up to $1.1 billion in regulatory and comme…
Eli Lilly and Company and AtaiBeckley Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health conditions, today announced a definitive agreement for Lilly to acquire AtaiBeckley. Emerging research indicates that treatment-resistant depression and other serious mental heal…
Medtronic plc, a global leader in healthcare technology, announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management. The acqu…
Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU (Lomustine) from Bristol Myers Squibb, Canada as of June 29th, 2026. This strategic acquisition marks a significant milestone in Septa's ongoing expansion and underscores its…
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd, a global leader in pharmaceutical manufacturing. The proposed alliance will be governed by definitive agreements to be discussed an…
Charles River Laboratories International, Inc. announced a collaboration with Arovella Therapeutics Ltd, a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS) services for cell characterization. The collaboration helps Arovella achieve its goal of creating a unique Inva…
Novartis announced that it has entered into an agreement to acquire Myricx Bio, a privately held UK-based biotechnology company developing a new class of antibody-drug conjugates (ADCs), using N-myristoyltransferase inhibitor (NMTi) payloads. The proposed acquisition would strengthen the Novartis oncology pipeline an…
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Nanoscope Therapeutics, a biotechnology company committed to commercializing novel, disease-agnostic, vision-restoring therapies for patients with photoreceptor loss due to retinal degeneration, announced an ex…
Page 3 of 37